• Patient Resource Type

  • PDF

• Language

  • English

Displaying results 1 - 12 of 14

Display:

12 24 48

Public Health and Advocacy

EASL Policy Statement on the Coexistence of Non-Alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease - EN

PDF

View

COVID-19 and the liver

EASL Policy Statement on the Use of COVID-19 Vaccines in People with Chronic Liver Disease, Hepatobiliary Cancer, and Liver Tr...

PDF

View

Public Health and Advocacy

EASL Policy Statement on Liver Disease and Migrant Health

PDF

View

Public Health and Advocacy

EASL Policy Statement on Screening of blood donations for hepatitis E virus (HEV)

PDF

View

Public Health and Advocacy

EASL Policy Statement on Reducing the burden of Alcohol Related Liver Disease (ARLD)

PDF

View

Public Health and Advocacy

EASL Policy Statement on Drug Use and the Global Hepatitis C Elimination Goal - EN

PDF

View

Public Health and Advocacy

EASL Policy Statement on Liver Cancer Screening

PDF

View

Public Health and Advocacy

EASL Policy Statement on Obesity is Feeding the Rise in Non-Alcoholic Fatty Liver Disease (NAFLD) across Europe

PDF

View

Public Health and Advocacy

EASL Policy Statement on Hepatitis C Elimination - EN

PDF

View

Public Health and Advocacy

EASL Policy Statement: risk-based surveillance for hepatocellular carcinoma among patients with cirrhosis

PDF

View

Public Health and Advocacy

EASL Policy Statement: Reducing alcohol harms

PDF

View

Metabolism, Alcohol & Toxicity

Non-alcoholic fatty liver disease: A patient guideline - GE version

PDF

View

Displaying results 1 - 12 of 14

Display:

12 24 48